SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN)

263 filings reported holding SUPN - SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q4 2016.
SUPERNUS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (SUPN) has 230 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 45.3M shares of 56M outstanding shares and own 80.88% of the company stock.
Largest 10 shareholders include BlackRock Fund Advisors (4.44M shares), VANGUARD GROUP INC (2.36M shares), Invesco Ltd. (1.94M shares), ACADIAN ASSET MANAGEMENT LLC (1.66M shares), Bank of New York Mellon Corp (1.59M shares), Ranger Investment Management, L.P. (1.44M shares), STATE STREET CORP (1.3M shares), BlackRock Institutional Trust Company, N.A. (1.23M shares), GLENMEDE TRUST CO NA (1.16M shares), and DIMENSIONAL FUND ADVISORS LP (1.11M shares).
This table shows the top 230 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.